Učitavanje...
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma
Bone marrow plasmacytoid dendritic cells (pDCs) in patients with multiple myeloma (MM) promote tumor growth, survival, drug resistance, and immune suppression. Understanding the molecular signaling crosstalk among the tumor cells, pDCs and immune cells will identify novel therapeutic approaches to e...
Spremljeno u:
| Izdano u: | Oncogene |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7132141/ https://ncbi.nlm.nih.gov/pubmed/32024967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1172-0 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|